# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-110972
Filing Date
2025-11-14
Accepted
2025-11-14 16:47:11
Documents
70
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0265115-10q_abpro.htm iXBRL | 10-Q | 1389671
2 | CERTIFICATION | ea026511501ex31-1_abpro.htm | EX-31.1 | 10213
3 | CERTIFICATION | ea026511501ex32-1_abpro.htm | EX-32.1 | 4085
| Complete submission text file | 0001213900-25-110972.txt |  | 7472389

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | abp-20250930.xsd | EX-101.SCH | 76411
5 | XBRL CALCULATION FILE | abp-20250930_cal.xml | EX-101.CAL | 33735
6 | XBRL DEFINITION FILE | abp-20250930_def.xml | EX-101.DEF | 404036
7 | XBRL LABEL FILE | abp-20250930_lab.xml | EX-101.LAB | 672265
8 | XBRL PRESENTATION FILE | abp-20250930_pre.xml | EX-101.PRE | 406861
72 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0265115-10q_abpro_htm.xml | XML | 765905

Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41224 | Film No.: 251487650
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)